Wang, R., Yang, Q., Luo, R., Peng, Y., Dai, S., Zhang, X., . . . Zheng, Y. (2014). Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Wang, Rui-Rui, et al. Azvudine, a Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-resistant Strains than Lamivudine in Vitro. Public Library of Science (PLoS), 2014.
Cita MLA (8a ed.)Wang, Rui-Rui, et al. Azvudine, a Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-resistant Strains than Lamivudine in Vitro. Public Library of Science (PLoS), 2014.